• Je něco špatně v tomto záznamu ?

Therapeutic potential of CDK11 in cancer

D. Blazek

. 2023 ; 13 (3) : e1201. [pub] -

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, práce podpořená grantem, komentáře

Perzistentní odkaz   https://www.medvik.cz/link/bmc23003917

Human cyclin-dependent kinases (CDKs) direct the progression of the cell cycle and transcription. They are deregulated in tumours, and despite their involvement in the regulation of basic cellular processes, many CDKs are promising targets for cancer therapy. CDK11 is an essential gene for the growth of many malignancies; however, its primary cellular function has been obscure, and the mode-of-action of OTS964, the first CDK11 inhibitor and antiproliferative compound, has been unknown. A recent study has shown that OTS964 prevents spliceosome activation, revealing a key role of CDK11 in the regulation of pre-mRNA splicing. In light of these findings, we discuss the therapeutic potential of CDK11 in cancer.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23003917
003      
CZ-PrNML
005      
20230425140955.0
007      
ta
008      
230418s2023 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ctm2.1201 $2 doi
035    __
$a (PubMed)36855776
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Blazek, Dalibor $u Central European Institute of Technology (CEITEC), Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000346629982
245    10
$a Therapeutic potential of CDK11 in cancer / $c D. Blazek
520    9_
$a Human cyclin-dependent kinases (CDKs) direct the progression of the cell cycle and transcription. They are deregulated in tumours, and despite their involvement in the regulation of basic cellular processes, many CDKs are promising targets for cancer therapy. CDK11 is an essential gene for the growth of many malignancies; however, its primary cellular function has been obscure, and the mode-of-action of OTS964, the first CDK11 inhibitor and antiproliferative compound, has been unknown. A recent study has shown that OTS964 prevents spliceosome activation, revealing a key role of CDK11 in the regulation of pre-mRNA splicing. In light of these findings, we discuss the therapeutic potential of CDK11 in cancer.
650    _2
$a lidé $7 D006801
650    _2
$a buněčný cyklus $7 D002453
650    _2
$a buněčné dělení $7 D002455
650    12
$a cyklin-dependentní kinasy $x genetika $7 D018844
650    12
$a nádory $x farmakoterapie $x genetika $7 D009369
650    _2
$a sestřih RNA $7 D012326
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a komentáře $7 D016420
773    0_
$w MED00193505 $t Clinical and translational medicine $x 2001-1326 $g Roč. 13, č. 3 (2023), s. e1201
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36855776 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425140951 $b ABA008
999    __
$a ok $b bmc $g 1924525 $s 1190126
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 13 $c 3 $d e1201 $e - $i 2001-1326 $m Clinical and translational medicine $n Clin Transl Med $x MED00193505
LZP    __
$a Pubmed-20230418
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace